News & Publications
Find our latest news and analysis here. From the daily Newsstand to the Quarterly Journal, we cover the full breadth of intellectual property law.
-
AIPLA Comments to USPTO on Trademark Fee Proposal
June 3, 2024
Arlington, VA. May 28, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO in in response to the Notice of Proposed Rulemaking on the Setting and Adjusting Trademark Fees During Fiscal Year 2025. -
AIPLA Comments to USPTO on Expanding Opportunities to Appear Before the Patent Trial and Appeal Board
May 24, 2024
Arlington, VA. May 21, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO in response to the Notice of Proposed Rulemaking on Expanding Opportunities to Appear Before the Patent Trial and Appeal Board (PTAB). -
AIPLA Comments on Inventorship Guidance for AI-Assisted Inventions
May 15, 2024
Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO in response to the recently-published Inventorship Guidance for AI-Assisted Inventions. -
AIPLA Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace
May 14, 2024
Arlington, VA. May 14, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the USPTO’s Request for Comment regarding Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace. -
AIPLA Files Amicus Brief in REGENXBIO Inc. v. Sarepta Therapeutics, Inc.
May 14, 2024
Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief in support of neither party with the Court of Appeals for the Federal Circuit in REGENXBIO Inc. v. Sarepta Therapeutics, Inc., a case on appeal from the U.S. District Court for the District of Delaware. The district court held that cultured host cells containing a recombinant nucleic acid molecule were not eligible for patent protection under Section 101 of the Patent Act because the individual nucleic acid sequences used in the recombinant molecule were not modified or changed from their naturally occurring state. -
Supreme Court Affirms Eleventh Circuit’s Ruling in Warner Chappell Music, Inc. v. Sherman Nealy
May 9, 2024
On May 9, 2024, the Supreme Court issued a 6-3 decision in Warner Chappell Music, Inc., et al. v. Sherman Nealy, et al., affirming the Eleventh Circuit’s ruling that, provided suit is timely filed under the discovery rule, copyright damages are recoverable for infringements occurring prior to the Copyright Act’s three-year statute of limitations. The majority opinion is consistent with the amicus brief filed by AIPLA on December 1, 2023. To read the opinion of the Court, please click here. -
AIPLA Comments to Copyright Office on Group Registration of Two-Dimensional Artwork
April 2, 2024
Arlington, VA. April 1, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office's Notice of Proposed Rulemaking related to group registration of two-dimensional artwork. -
AIPLA Files Amicus Brief with the Court of Appeals for the Federal Circuit in Google LLC v. Sonos, Inc.
March 21, 2024
Arlington, VA. February 29, 2024 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief in support of neither party with the Court of Appeals for the Federal Circuit in Google LLC v. Sonos, Inc., a case on appeal from the U.S. District Court for the Northern District of California. The district court held that the post-GATT patents-in-suit are unenforceable under the doctrine of prosecution laches and found unreasonable and inexcusable delay where 13 years had elapsed between the provisional patent application and presenting the claims at issue. -
AIPLA Comments to Copyright Office on Group Registration of Updates to a News Website
February 22, 2024
Arlington, VA. February 20, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office's Notice of Proposed Rulemaking related to group registration of updates to a news website. -
AIPLA Comments to HHS on WHO Pandemic Treaty
February 8, 2024
Arlington, VA. January 31, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the RFC on Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the World Health Organization (WHO) Pandemic Agreement.
Broadcast Opportunities
Looking for opportunities to get published? Submit your work to the AIPLA Quarterly Journal or AIPLA Innovate Magazine.
Exhibitor and Sponsorship Opportunities
Highlight your brand at a premier intellectual property law event, webinar, podcast, or in one of our publications.
For rates, availability, or additional details, click here or contact:
Meghan Donohoe
COO
American Intellectual Property Law Association (AIPLA)
T| +1.703.415.1343
E| mdonohoe@aipla.org